<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>INTRODUCTION: <z:hpo ids='HP_0011663'>Arrhythmogenic right ventricular cardiomyopathy</z:hpo> (ARVC) is a major cause of <z:hpo ids='HP_0001645'>sudden cardiac death</z:hpo> due to tachyarrhythmias </plain></SENT>
<SENT sid="1" pm="."><plain>The purpose of this study was to investigate the long-term prognosis in patients with ARVC and the incidence of rapid <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> during follow-up </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Thirty ARVC patients (19 male, 63.3%, mean age 48 ± 15 years) fulfilling modified Task Force criteria 2010 were included </plain></SENT>
<SENT sid="3" pm="."><plain>Of them, 13 patients (43.3%) received implantable cardioverter-defibrillator (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e>) implantation </plain></SENT>
<SENT sid="4" pm="."><plain>Rapid <z:hpo ids='HP_0004308'>ventricular arrhythmia</z:hpo> was defined as electrical storm or the occurrence of <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> (VT) or <z:hpo ids='HP_0001663'>ventricular fibrillation</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e>) with a cycle length of 240 ms or less that necessitate shock delivery to 2 or more times within a 24-hour period </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: With a mean follow-up of 68 ± 10 months, 6 patients (20%) with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> implantation had recurrent rapid VT/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>One (3.3%) of them died of multiple shocks and SCD, and 5 (16.7%) had multiple <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> therapies due to VT/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> and electrical storm </plain></SENT>
<SENT sid="7" pm="."><plain>The interval between the diagnosis of ARVC and occurrence of rapid VT/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> was 13.4 ± 4.9 months </plain></SENT>
<SENT sid="8" pm="."><plain>Most (5/6, 83.3%) events of recurrent rapid VT/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> occurred within 2 years </plain></SENT>
<SENT sid="9" pm="."><plain>Ablated patients who did not receive an <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> implant were totally free of rapid VT/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: For patients with ARVC, long-term prognosis is favorable </plain></SENT>
<SENT sid="11" pm="."><plain>During a long-term follow-up, patients meeting the criteria for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> implantation have a higher rate of rapid and potentially life-threatening <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>However, early and clustered recurrence of rapid VT/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> in patients with an <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> is common, whereas late occurrence of rapid VT/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> is very rare </plain></SENT>
</text></document>